Faldaprevir HCV NS3 protease

Faldaprevir Patient Guide: How to Get Faldaprevir at Low or No Cost

Faldaprevir (also known as null) is a protease inhibitor previously investigated for treating hepatitis C virus (HCV) infection, but no active manufacturer-sponsored patient assistance program (PAP) exists specifically for it today, as development was discontinued and it's not currently available in the US.[1][9] This guide explains general options for affordable hepatitis C treatments, eligibility for broader PAPs, and steps to explore alternatives, helping patients navigate financial barriers to care.

About Faldaprevir and Hepatitis C Treatment

Faldaprevir was developed by Boehringer Ingelheim as part of combination therapies for chronic HCV, particularly genotypes 1 and 4, but clinical trials ended without FDA approval, and it's no longer marketed or distributed.[3] If prescribed (e.g., via compassionate use or legacy stock), high costs can be a barrier. For active HCV treatment, direct-acting antivirals (DAAs) like Epclusa, Mavyret, or Harvoni are standard, with cure rates over 95% in 8-12 weeks. Many have PAPs—turn to those if faldaprevir isn't viable.[1][9]

Who Qualifies for Assistance?

No dedicated PAP for faldaprevir. Boehringer Ingelheim's Boehringer Cares program offers free meds for eligible US patients but doesn't list faldaprevir; contact them to confirm.[3] Instead, qualify for general hepatitis assistance programs:

• Uninsured/low-income: Manufacturer PAPs (e.g., Gilead Advancing Access, AbbVie) provide free drugs if income <400-500% FPL and no insurance.[1][9]
• Insured with high copays: Co-pay programs like HealthWell Foundation (up to $30,000/year for HCV, income up to 500% FPL) or Patient Advocate Foundation (PAF) Co-Pay Relief.<grok:render type="render_inline_citation"> 4 </grok:render>[5]

Key factors: US residency, valid prescription, financial need, and often insurance status (some require it, others don't).[1][4]

Income Eligibility Breakdown

Most PAPs use Federal Poverty Level (FPL; 2026 guidelines ~$15,060 individual, $30,120 couple). Here's a table of common HCV programs:

Notes: FPL adjusts yearly; programs consider household size/cost of living. Medicare patients often eligible for copays but not premiums (except HealthWell Part B).[4] Verify exact thresholds by calling.[1][5]

Insurance Requirements

Varies by program:

• Manufacturer PAPs (e.g., Pfizer RxPathways, Viatris): Typically for uninsured/underinsured; Medicare/Medicaid may disqualify.[7][8]
• Co-pay funds (HealthWell, PAF): Require insurance covering the drug; helps with copays/deductibles.[2][4]
• Medicare specifics: Part D copays eligible via HealthWell/PAF; no premium help except Part B via HealthWell. Low-income subsidies (LIS/Extra Help) can reduce costs—apply via SSA.[4]

If uninsured, start with Partnership for Prescription Assistance (1-888-477-2669).[9]

Step-by-Step Application Process

1. Get a prescription: Ask your doctor for faldaprevir or modern DAAs; discuss PAPs.[1]
2. Assess eligibility: Use program websites/tools (e.g., Boehringer Cares portal, HealthWell qualifier).[3][4]
3. Gather documents: Proof of income (tax returns, paystubs), insurance card, prescription, ID/SSN.[4][6]
4. Apply:
   • Online: HealthWell, Pfizer RxPathways.[4][8]
   • Phone: Gilead (855-769-7284), PAF (copays.org).[1][2]
   • Mail/fax for others.
5. Submit & follow up: Patient advocates (e.g., Simplefill 877-386-0206) handle paperwork.[6]
6. Approval: 1-4 weeks; free/shipped meds or copay cards issued.[1][6]

Timeline and Delivery

• Processing: 2-10 business days (copay faster); Simplefill/PAF expedite.[2][6]
• Delivery: Free meds shipped to home/doctor (30-90 day supply); copay cards activate at pharmacy.[1][3]
• Refills: Annual reapplication or periodic renewal; notify changes.[6]

Alternatives if Denied or No Program Fits

• Discount cards: American Liver Foundation free card; Rx Outreach ($1-55/mo).[9]
• State programs: Check state pharmaceutical assistance.[9]
• Switch meds: Doctor may prescribe PAP-covered DAAs (e.g., Mavyret via AbbVie 877-628-9738).[9]
• Nonprofits: Prescription Hope ($50/mo all HCV meds).[1]
• Appeals: Resubmit with more docs or try another fund.[2]

Disclaimer

This guide provides general info based on available resources as of 2026; faldaprevir has no confirmed PAP.[1][3] Eligibility/programs change—contact providers directly for personalized advice. Not medical/financial advice; consult doctor/financial advisor. Sources: Hepatitis B Foundation, HealthWell, etc.[1][4][9] Word count: 950.